You have 9 free searches left this month | for more free features.

Dermatomyositis

Showing 1 - 25 of 251

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Severity in Juvenile and Adult-onset Dermatomyositis

Not yet recruiting
  • Dermatomyositis
  • evaluation of clinical severity
  • (no location specified)
Aug 16, 2023

Lymphocyte Subsets of Peripheral Blood in Nonmyopathic

Recruiting
  • Dermatomyositis
    • Jinan, Shandong, China
      Yanfeng Hou
    Nov 19, 2023

    Dermatomyositis, Adult Type Trial (Itolizumab)

    Not yet recruiting
    • Dermatomyositis, Adult Type
    • (no location specified)
    Aug 3, 2023

    Tp-e Interval and Tp-e/QT Ratio in Dermatomyositis and Analysis

    Recruiting
    • Dermatomyositis
    • +2 more
      • Zhejiang, Hangzhou, China
        The Third People's Hospital of Hangzhou
      Aug 21, 2023

      Polymyositis, Dermatomyositis Trial in Gainesville (Umbilical Cord Lining Stem Cells)

      Active, not recruiting
      • Polymyositis
      • Dermatomyositis
      • Umbilical Cord Lining Stem Cells
      • Gainesville, Florida
        University of Florida
      Jan 31, 2023

      Autoinflammatory Diseases Including Juvenile Dermatomyositis

      Recruiting
      • Autoinflammatory Disease
      • Juvenile Dermatomyositis
        • Bethesda, Maryland
          National Institutes of Health Clinical Center
        Jan 25, 2023

        Dermatomyositis Trial in DeBary (GLPG3667, Placebo)

        Not yet recruiting
        • Dermatomyositis
        • DeBary, Florida
          Omega Research Consultants
        Jan 13, 2023

        Clinical Analysis of Juvenile Dermatomyositis Patients

        Completed
        • Juvenile Dermatomyositis
        • observation
        • (no location specified)
        Aug 18, 2022

        Dermatomyositis Trial (Interleukin-2)

        Not yet recruiting
        • Dermatomyositis
        • (no location specified)
        Aug 8, 2022

        Dermatomyositis, Polymyositis Trial in Orlando (M5049 high dose, Placebo)

        Recruiting
        • Dermatomyositis
        • Polymyositis
        • M5049 high dose
        • Placebo
        • Orlando, Florida
          HMD Research LLC
        Jan 30, 2023

        Dermatomyositis, Idiopathic Inflammatory Myopathies Trial run by the National Institute of Environmental Health Sciences (NIEHS)

        Active, not recruiting
        • Dermatomyositis
        • Idiopathic Inflammatory Myopathies
        • Sodium Thiosulfate
        • Bethesda, Maryland
          National Institutes of Health Clinical Center
        Nov 8, 2022

        Study and Treatment of Inflammatory Muscle Diseases

        Recruiting
        • Dermatomyositis
        • Polymyositis
          • Bethesda, Maryland
            National Institutes of Health Clinical Center
          Jan 21, 2023

          Dermatomyositis Trial in Nanchang (Lenalidomide)

          Not yet recruiting
          • Dermatomyositis
          • Nanchang, Jiangxi, China
            Department of Rheumatology and Clinical Immunology, Jiangxi Prov
          Aug 3, 2022

          Gastric Mucosal Changes in Patients With Dermatomyositis

          Recruiting
          • Gastric Mucosal Manifestations in Patients With Dermatomyositis
            • Hangzhou, Zhejiang, China
              Second Affiliated Hospital of Zhejiang University School of Medi
            May 30, 2022

            Dermatomyositis Trial in Paris (Baricitinib, Placebo)

            Not yet recruiting
            • Dermatomyositis
            • Paris, France
              Pitie-Salpêtrière hospital APHP
            Jun 7, 2022

            Idiopathic Inflammatory Myositis Trial (Daxdilimab, Placebo)

            Not yet recruiting
            • Idiopathic Inflammatory Myositis
            • (no location specified)
            Dec 20, 2022

            Plexin D1 as a Potential Biomarker inPM/DM

            Not yet recruiting
            • Polymyositis
            • Dermatomyositis
            • plexinD1
            • (no location specified)
            Nov 25, 2022

            Dermatomyositis Trial in Seattle (Baricitinib)

            Not yet recruiting
            • Dermatomyositis
            • Seattle, Washington
              University of Washington Medical Center
            Apr 29, 2022

            Dermatomyositis Trial in Orlando, Plantation (Brepocitinib, Placebo)

            Recruiting
            • Dermatomyositis
            • Orlando, Florida
            • +1 more
            Jun 24, 2022

            Polymyositis, Dermatomyositis Trial in Seoul (PN-101)

            Enrolling by invitation
            • Polymyositis
            • Dermatomyositis
            • PN-101
            • Seoul, Korea, Republic of
            • +2 more
            Jun 10, 2022

            Dermatomyositis Trial in Strasbourg (exploration)

            Recruiting
            • Dermatomyositis
            • exploration
            • Strasbourg, France
              Meyer
            Aug 18, 2022

            Environmental Risk Factors for the Anti-synthetase Syndrome

            Recruiting
            • Myositis
            • +4 more
              • Bethesda, Maryland
              • +1 more
              Jan 7, 2023

              Treatment Side Effects Trial in Sao Paulo (Lipid-lowering agents (Artovastatin))

              Terminated
              • Treatment Side Effects
              • Lipid-lowering agents (Artovastatin)
              • Sao Paulo, Brazil
                Samuel Katsuyuki Shinjo
              May 31, 2022

              Myositis Trial in Upland, Orlando, Saint Louis (PF-06823859, Placebo)

              Recruiting
              • Myositis
              • Upland, California
              • +4 more
              May 29, 2023

              Clinical Responsiveness of Dermatomyositis Using Cutaneous

              Recruiting
              • Dermatomyositis
                • Philadelphia, Pennsylvania
                  Hospital of the University of Pennsylvania
                Jan 29, 2022